APA način citiranja

Gettinger, S. N., Redman, M. W., Bazhenova, L., Hirsch, F. R., Mack, P. C., Schwartz, L. H., . . . Herbst, R. S. (2021). Nivolumab Plus Ipilimumab vs Nivolumab for Previously Treated Patients With Stage IV Squamous Cell Lung Cancer: The Lung-MAP S1400I Phase 3 Randomized Clinical Trial. JAMA Oncol.

Čikaški stil citiranja

Gettinger, Scott N., et al. "Nivolumab Plus Ipilimumab Vs Nivolumab for Previously Treated Patients With Stage IV Squamous Cell Lung Cancer: The Lung-MAP S1400I Phase 3 Randomized Clinical Trial." JAMA Oncol 2021.

MLA način citiranja

Gettinger, Scott N., et al. "Nivolumab Plus Ipilimumab Vs Nivolumab for Previously Treated Patients With Stage IV Squamous Cell Lung Cancer: The Lung-MAP S1400I Phase 3 Randomized Clinical Trial." JAMA Oncol 2021.